Rank #1042BMRN

BioMarin Pharmaceutical Inc.

$63.42

2.57% (Daily)

Market Cap

$12.18B

Revenue

$3.09B

Rank by MCap

#1042

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Alexander Hardy

Headquarters

San Rafael, CA

Employees

3,040

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic ...